|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent Staar Surgical insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why Staar Surgical insider buys are important for investors to follow.
Date | Insider | Price | Amount |
3-14-2024 Insider Buy |
Aimee S. Weisner
|
$38.11
CAGR »
|
$66,692.50 1,750 shares |
1-8-2024 Insider Buy |
BROADWOOD PARTNERS, L.P. >10% Owner |
$27.11
CAGR »
|
$109,570.13 4,042 shares |
1-5-2024 Insider Buy |
BROADWOOD PARTNERS, L.P. >10% Owner |
$28.61
CAGR »
|
$6,481,556.91 226,553 shares |
12-6-2023 Insider Buy |
Lilian Yansheng Zhou Director |
$30.74
CAGR »
|
$26,129.00 850 shares |
11-30-2023 Insider Buy |
BROADWOOD PARTNERS, L.P. >10% Owner |
$31.50
CAGR »
|
$13,703,830.51 434,991 shares |
11-13-2023 Insider Buy |
BROADWOOD PARTNERS, L.P. >10% Owner |
$32.74
CAGR »
|
$1,140,132.19 34,827 shares |
11-9-2023 Insider Buy |
BROADWOOD PARTNERS, L.P. >10% Owner |
$33.42
CAGR »
|
$9,662,781.63 289,140 shares |
11-6-2023 Insider Buy |
BROADWOOD PARTNERS, L.P. >10% Owner |
$34.93
CAGR »
|
$10,797,514.02 309,154 shares |
10-6-2023 Insider Buy |
BROADWOOD PARTNERS, L.P. >10% Owner |
$37.81
CAGR »
|
$7,762,465.77 205,296 shares |
9-21-2023 Insider Buy |
Elizabeth Yeu Lin Director |
$40.00
CAGR »
|
$100,000.00 2,500 shares |
9-21-2023 Insider Buy |
BROADWOOD PARTNERS, L.P. >10% Owner |
$40.12
CAGR »
|
$11,689,353.91 291,383 shares |
9-7-2023 Insider Buy |
BROADWOOD PARTNERS, L.P. >10% Owner |
$41.42
CAGR »
|
$7,868,912.71 189,962 shares |
8-7-2023 Insider Buy |
Aimee S. Weisner Director |
$48.72
CAGR »
|
$97,440.00 2,000 shares |
12-29-2022 Insider Buy |
BROADWOOD PARTNERS, L.P. >10% Owner |
$47.42
CAGR »
|
$9,061,575.02 191,075 shares |
5-3-2019 Insider Buy |
BROADWOOD PARTNERS, L.P. >10% Owner |
$22.23
CAGR »
|
$2,223,000.00 100,000 shares |
6-29-2016 Insider Buy |
Partners LP Broadwood >10% Owner |
$5.24
CAGR »
|
$74,081.05 14,144 shares |
5-25-2016 Insider Buy |
Partners LP Broadwood >10% Owner |
$5.16
CAGR »
|
$401,729.01 77,842 shares |
5-17-2016 Insider Buy |
Partners LP Broadwood >10% Owner |
$5.23
CAGR »
|
$48,693.02 9,313 shares |
5-16-2016 Insider Buy |
Partners LP Broadwood >10% Owner |
$5.49
CAGR »
|
$1,847,432.37 336,210 shares |
2-11-2016 Insider Buy |
Partners LP Broadwood >10% Owner |
$6.01
CAGR »
|
$3,329,936.66 554,066 shares |
2-9-2016 Insider Buy |
Partners LP Broadwood >10% Owner |
$6.25
CAGR »
|
$573,206.61 91,770 shares |
2-3-2016 Insider Buy |
Partners LP Broadwood >10% Owner |
$6.40
CAGR »
|
$778,812.46 121,599 shares |
2-1-2016 Insider Buy |
Partners LP Broadwood >10% Owner |
$6.48
CAGR »
|
$427,634.59 65,983 shares |
1-27-2016 Insider Buy |
Partners LP Broadwood >10% Owner |
$6.63
CAGR »
|
$1,585,799.59 239,013 shares |
1-20-2016 Insider Buy |
Partners LP Broadwood >10% Owner |
$6.75
CAGR »
|
$491,620.98 72,858 shares |
1-15-2016 Insider Buy |
Partners LP Broadwood >10% Owner |
$6.73
CAGR »
|
$913,178.51 135,725 shares |
1-11-2016 Insider Buy |
Partners LP Broadwood >10% Owner |
$6.83
CAGR »
|
$591,485.07 86,586 shares |
1-7-2016 Insider Buy |
Partners LP Broadwood >10% Owner |
$6.95
CAGR »
|
$1,856,079.29 267,047 shares |
1-4-2016 Insider Buy |
Partners LP Broadwood >10% Owner |
$7.11
CAGR »
|
$1,176,187.92 165,461 shares |
9-29-2015 Insider Buy |
Partners LP Broadwood >10% Owner |
$7.08
CAGR »
|
$2,203,748.70 311,099 shares |
8-25-2015 Insider Buy |
Partners LP Broadwood >10% Owner |
$7.17
CAGR »
|
$1,354,241.46 188,881 shares |
8-10-2015 Insider Buy |
Lou Silverman Director |
$8.18
CAGR »
|
$12,273.00 1,500 shares |
8-6-2015 Insider Buy |
Jack Steven Roush Director |
$8.08
CAGR »
|
$8,079.90 1,000 shares |
11-19-2014 Insider Buy |
Partners LP Broadwood >10% Owner |
$8.64
CAGR »
|
$1,639,210.21 189,646 shares |
11-10-2014 Insider Buy |
Partners LP Broadwood >10% Owner |
$8.79
CAGR »
|
$4,395.00 500 shares |
11-7-2014 Insider Buy |
Partners LP Broadwood >10% Owner |
$8.92
CAGR »
|
$713,626.00 80,000 shares |
11-4-2014 Insider Buy |
Partners LP Broadwood >10% Owner |
$9.20
CAGR »
|
$2,394,256.53 260,341 shares |
12-11-2012 Insider Buy |
John C. Moore Director |
$5.46
CAGR »
|
$27,300.00 5,000 shares |
11-15-2012 Insider Buy |
Partners LP Broadwood >10% Owner |
$5.00
CAGR »
|
$13,090.00 2,618 shares |
11-15-2012 Insider Buy |
Mark B. Logan Director |
$5.22
CAGR »
|
$18,807.90 3,600 shares |
11-14-2012 Insider Buy |
Barry G. Caldwell President and CEO |
$5.04
CAGR »
|
$25,200.00 5,000 shares |
11-2-2012 Insider Buy |
Partners LP Broadwood >10% Owner |
$5.00
CAGR »
|
$112,853.23 22,572 shares |
8-9-2012 Insider Buy |
Barry G. Caldwell President and CEO |
$6.57
CAGR »
|
$32,826.50 5,000 shares |
8-2-2012 Insider Buy |
Partners LP Broadwood >10% Owner |
$5.14
CAGR »
|
$1,524,171.23 296,718 shares |
5-23-2012 Insider Buy |
Mark B. Logan Director |
$8.75
CAGR »
|
$26,250.00 3,000 shares |
5-29-2012 Insider Buy |
Barry G. Caldwell President and CEO |
$8.86
CAGR »
|
$44,280.50 5,000 shares |
5-9-2011 Insider Buy |
John C. Moore Director |
$5.43
CAGR »
|
$27,141.50 5,000 shares |
4-20-2011 Insider Buy |
Partners LP Broadwood >10% Owner |
$4.54
CAGR »
|
$102,147.75 22,500 shares |
Also See: Institutional Holders of STAA
Also See: SEC filings
Below we present the annualized performance delivered by Staar Surgical stock since 3-14-2024 (the date of the most recent
insider purchase). The performance of the investment from the time Staar Surgical insider buying occurred is the ultimate
test of whether insiders were right about STAA being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/15/2024 |
|
End date: |
04/17/2024 |
|
Start price/share: |
$37.72 |
|
End price/share: |
$46.34 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
22.85% |
|
Annualized Gain: |
252.76% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$12,285.00 |
|
Years: |
0.09 |
|
Staar Surgical Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Staar Surgical insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding STAA
|
|